BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• 

  Earnings

  Regeneron Shares Tumble as Eylea Declines Make for a ‘Messy Quarter’ To Come

  The company’s $3 billion in earnings for the first quarter missed on both top and bottom line, according to BMO Capital Markets. Adding insult to injury, the FDA declined to approve a prefilled syringe of its ophthalmology cornerstone.

  April 29, 2025

   · 

  1 min read

   · 

  Annalee Armstrong
• Press Releases

  RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)

  April 29, 2025

   · 

  19 min read
• Press Releases

  Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care

  April 29, 2025

   · 

  2 min read
• Press Releases

  NeoGenomics Reports First Quarter 2025 Results

  April 29, 2025

   · 

  19 min read
• Press Releases

  Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

  April 29, 2025

   · 

  6 min read
• Press Releases

  Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis

  April 29, 2025

   · 

  18 min read
• Press Releases

  AtriCure Reports First Quarter 2025 Financial Results

  April 29, 2025

   · 

  11 min read
• Press Releases

  D3 Bio Announces Nature Medicine Publication and AACR 2025 Presentation Highlighting D3S-001 as a Next-Generation KRAS G12C Inhibitor with Best-in-Class Potential

  April 29, 2025

   · 

  4 min read
• Press Releases

  BD Board Declares Dividend

  April 29, 2025

   · 

  1 min read
• Press Releases

  Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew

  April 29, 2025

   · 

  4 min read